Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Med Genet A ; 132A(1): 80-3, 2005 Jan 01.
Article in English | MEDLINE | ID: mdl-15580638

ABSTRACT

Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder of glyoxylate metabolism, in which excessive oxalates are formed by the liver and excreted by the kidneys, causing a wide spectrum of disease, ranging from renal failure in infancy to mere renal stones in late adulthood. This disease is caused by a deficiency of alanine:glyoxylate aminotransferase (AGT), which is encoded by a single copy gene, AGXT, located in 2q37.3. We identified an apparently homozygous, loss-of-function, mutation in a patient; the gene defect was present in the heterozygous mother but not in the patient's father. We performed a microsatellite repeat analysis using 13 specific chromosome 2 markers and non-chromosome 2 minisatellites. Six specific chromosome 2 markers showed an apparently homozygous maternal inheritance while four showed a biparental transmission consistent with paternity (confirmed by minisatellite analysis). Quantitative PCR of AGXT exons 1 and 3 on the patient's and parents genomic DNA revealed the presence of two copies of the gene. This is the first case of PH1 caused by segmental maternal isodisomy of 2q37.3.


Subject(s)
Chromosomes, Human, Pair 2/genetics , Hyperoxaluria, Primary/genetics , Telomere/genetics , Uniparental Disomy , Alleles , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Female , Frameshift Mutation , Homozygote , Humans , Hyperoxaluria, Primary/enzymology , Male , Microsatellite Repeats , Mothers , Mutagenesis, Insertional , Transaminases/genetics
2.
BMC Med Genet ; 5: 19, 2004 Aug 02.
Article in English | MEDLINE | ID: mdl-15287992

ABSTRACT

BACKGROUND: To contribute further to the classification of three CFTR amino acid changes (p.I148T, p.R74W and p.D1270N) either as CF or CBAVD-causing mutations or as neutral variations. METHODS: The CFTR genes from individuals who carried at least one of these changes were extensively scanned by a well established DGGE assay followed by direct sequencing and familial segregation analysis of mutations and polymorphisms. RESULTS: Four CF patients (out of 1238) originally identified as carrying the p.I148T mutation in trans with a CF mutation had a second mutation (c.3199del6 or a novel mutation c.3395insA) on the p.I148T allele. We demonstrate here that the deletion c.3199del6 can also be associated with CF without p.I148T. Three CBAVD patients originally identified with the complex allele p.R74W-p.D1270N were also carrying p.V201M on this allele, by contrast with non CF or asymptomatic individuals including the mother of a CF child, who were carrying p.R74W-p.D1270N alone. CONCLUSION: These findings question p.I148T or p.R74W-p.D1270N as causing by themselves CF or CBAVD and emphazises the necessity to perform a complete scanning of CFTR genes and to assign the parental alleles when novel missense mutations are identified.


Subject(s)
Amino Acid Substitution , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Mutation , Cystic Fibrosis/pathology , DNA Mutational Analysis , Family Health , Female , Gene Frequency , Haplotypes , Humans , Male , Mutagenesis, Insertional , Penetrance , Polymorphism, Genetic , Sequence Deletion
SELECTION OF CITATIONS
SEARCH DETAIL
...